The lancet. Diabetes & endocrinology
The most recent articles from:
Lancet Diabetes Endocrinol
-
Lancet Diabetes Endocrinol · Sep 2013
Randomized Controlled Trial Multicenter StudyEffect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial.
Effective reduction of albuminuria and blood pressure in patients with type 2 diabetes who have nephropathy is seldom achieved with available treatments. We tested the effects of treatment of such patients with daglutril, a combined endothelin-converting enzyme and neutral endopeptidase inhibitor. ⋯ Solvay Pharmaceuticals.